Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123091) titled 'To observe the effect of human ultra-long-acting GLP-1RA on the weight and gonadal function of overweight or obese patients' on April 21.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
Overweight
Obesity
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-04-22
Target Sample Size: Drug Treatment Group:45;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=319277
Published by HT Digital Content Services with permission from Health Daily Digest....